Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection.

Rolland, Morgane; Gilbert, Peter B

Rolland, Morgane; Gilbert, Peter B.

Rolland M; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.
Gilbert PB; Emerging Infectious Diseases Branch, Walter Reed Army Institute of Research, Silver Spring, Maryland, United States of America.

PLoS Pathog ; 17(3): e1009406, 2021 03.

Article in English | MEDLINE | ID: covidwho-1403326

Subject(s)

COVID-19 Vaccines/therapeutic use; COVID-19/prevention & control; COVID-19/virology; SARS-CoV-2/immunology; Spike Glycoprotein, Coronavirus/genetics; COVID-19/genetics; COVID-19/immunology; COVID-19 Vaccines/immunology; Genetic Variation/immunology; Humans; SARS-CoV-2/genetics; Sequence Analysis, DNA/methods; Spike Glycoprotein, Coronavirus/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Spike Glycoprotein, Coronavirus / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies Topics: Vaccines Limits: Humans Language: English Journal: PLoS Pathog Year: 2021 Document Type: Article Affiliation country: JOURNAL.PPAT.1009406

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google